Helicobacter

Article	Citations
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort	45
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults	37
	37
Issue Information	31
Helicobacter macacaeMazF interplays with Escherichia coli homologs and enhances antibiotic tolerance	30
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	30
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug	30
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021	28
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	26
Constitutive programmed death ligand 1 expression protects gastric G‐cells from Helicobacter pylori–induced inflammation	25
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	24
Issue Information	24
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori	23
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	23
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial	22
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	22
Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study	21
Helicobacter pylori, gastrointestinal microbiota, and immunotherapy	21
Issue Information	21
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	21
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study	20
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis	20
Integrin‐Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential	20
Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study	19
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor	19

Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori	19
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial	19
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection	19
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review	19
Issue Information	18
Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in	17
Colloidal bismuth pectin‐containing quadruple therapy as the first‐line treatment of Helicobacter pylori infection: A multicenter, randomized, double‐blind, non‐inferiority clinical trial	17
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children	17
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia	16
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	16
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target	15
Issue Information	15
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions	15
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020	15
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	15
Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis	15
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis	15
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	15
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China	15
Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices	15
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	14
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	14
Helicobacter pylori enhances HLA‐C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells	14
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	14
Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy	14
Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in	14
Effect ofHelicobacter pylorion immunotherapy is gaining more attention	13
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	13
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	13
Impact of body size on efficacy of high‐dose dual therapy for Helicobacter pylori eradication	12
Transmission ofHelicobacter pyloribetween a human and two dogs: A case report	12
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	12
Helicobacter pylori and the intestinal microbiome among healthy school‐age children	12
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	12
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	12
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	12
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	11
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	11
Ethnic Inequity in the Current Approach to H. pylori Testing and Treatment: Linked Data Cohort Analysis	11
CRISPR‐based detection of Helicobacter pylori in stool samples	11
Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy	11
	11
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	11
	10
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”	10
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	10
Issue Information	10
	10
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up	10
Helicobacter pylori regulated microRNA map of human gastric cells	10

Issue Information	10
Issue Information	10
	10
	10
Combatting Helicobacter pylori: A Focus on Nanomaterials	9
The first 5 years of Helicobacter pylori research—With an emphasis on the United Kingdom	9
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	9
The association between Helicobacter pylori and gastrointestinal disorders during pregnancy: A Multicenter retrospective study	9
Corrigendum	9
Helicobacter pylori induced reactive oxygen Species: A new and developing platform for detection	9
Issue Information	8
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	8
	8
Gastric granulomas and Helicobacter pylori: An incidental relationship	8
	8
“Helicobacter pylori in familial mediterranean fever: A series of 120 patients from literature and from france”	8
Cover Image	8
	8
	8
Issue Information	8
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	8
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article	8
Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacterpylori	7
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy	7
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence	7
Effects of sodium butyrate supplementation on inflammation, gut microbiota, and short‐chain fatty acids in Helicobacter pylori‐infected mice	7
Real‐world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia	7
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	7
Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection	7
Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis	7
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy	7
CCR6+ T helper cells and regulatory T cells in the blood and gastric mucosa during Helicobacter pylori infection	7
Association of Helicobacter pylori with migraine headaches and the effects of this infection and its eradication on the migraine characteristics in adults: A comprehensive systematic review and	7
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans	7
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis	7
Improved Patient Adherence to Family‐Based Helicobacter pylori Infection Control and Management Strategy in Central China and Its Influencing Factors	6
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	6
Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial	6
Application of WeChat platform in the management of patients infected with Helicobacter pylori	6
Issue Information	6
Dynamic changes in antibiotic resistance genes and gut microbiota afterHelicobacter pylorieradication therapies	6
Issue Information	6
Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis	6
Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation	6
Rapid Antimicrobial Susceptibility Test of Helicobacter pylori to Metronidazole via Single‐Cell Raman Spectrometry	6
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation	6
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	6
Comparison of clinical outcomes and FOXP3, IL‐17A responses in Helicobacter pylori infection in children versus adults	6
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	6
Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway	6
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro	6
Gastric Cancer Screening: Intention to Adhere and Patients' Perspective	6
Evaluation of the effects of a proton pump inhibitor on Helicobacter pylori stool antigen testing	6
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing	6
Pepsinogen II in gastritis and Helicobacter pylori infection	5
	5
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia	5
Helicobacter pyloriresults in lysis and death after exposure to water	5
Time trend prevalence of helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019	5
Validation and improvement of a multiplex PCR method to detect murine Helicobacter species in feces samples of mice	5
Two novel sequence types of Helicobacter pylori strains: The first report from Turkey	5
Helicobacterspecies binding to the human gastric mucosa	5
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial	5
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes	5
Association between Helicobacter pylori infection and growth outcomes in children: A meta‐analysis	5
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	5
Issue Information	5
Cover Image	5
	5
Treatment failure is a key factor in the development of Helicobacter pylori resistance	5
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice	5
Helicobacter pylori antigens as immunomodulators of immune system	4
Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis	4
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	4
Discussion on the common controversies of Helicobacter pylori infection	4
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	4
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals	4
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	4
Regulatory B cells (Bregs) in Helicobacter pylori chronic infection	4
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	4

Perspectives from recent advances of Helicobacter pylori vaccines research	4
An increasing trend of gastric cancer deaths and inadequate preventive measures in elderly adults	4
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?	4
14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority contro	3
	3
Helicobacter pylori with trx1 high expression promotes gastric diseases via upregulating the IL23A/NF‐κB/IL8 pathway	3
Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis	3
States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis	3
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	3
Prevalence of Helicobacter pylori infection among Slovenian children and adolescents: A prospective cohort study	3
Achieving Helicobacter pylori eradication in the primary treatment requires a deep integration of personalization and standardization	3
Volatilomic signatures of different strains of Helicobacter pylori	3
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection	3
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	3
Transcriptomic remodeling of gastric cells by Helicobacter pylori outer membrane vesicles	3
Helicobacter pylori‐Associated Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Tissue in Children: A Multicenter Case Series	3
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study	3
Diagnostic performance of linked color imaging for gastric cancer by Helicobacter pylori infection status: A subanalysis of the large‐scale, multicenter randomized controlled trial <	3
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases	3
Helicobacter pylori infection and risk of cardiovascular disease	3
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	2
	2
Long‐term improvement in constipation‐related symptoms after Helicobacter pylori eradication therapy	2
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	2
Correction to Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	2
Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis	2
	2
Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?	2
Issue Information	2
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea	2
Effects of non‐viableLactobacillus reutericombining with 14‐day standard triple therapy onHelicobacter pylorieradication: A randomized double‐blind placebo‐controlled trial	2
Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study	2
Comparative analysis of large language models in medical counseling: A focus on Helicobacter pylori infection	2
Doxycycline and minocycline inHelicobacter pyloritreatment: A systematic review and meta‐analysis	2
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	2
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	2
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	2
In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori	2
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study	2
Genome‐wide association study of Helicobacter pylori serological status in Latin American children	2
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	2
Impact of smoking on the eradication of Helicobacter pylori	2
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	2
Issue Information	2
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells	2
Changes of 18F‐fluoro‐2‐deoxyglucose position‐emission tomography findings by the eradication of Helicobacter pylori in the stomach	1
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial	1
Declining trends of prevalence ofHelicobacter pyloriinfection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis	1
Oral immunotherapy for Helicobacter pylori: Can it be trusted? A systematic review	1
Does technology‐enhanced communication improve Helicobacter pylori eradication outcomes?—A meta‐analysis	1
Pilot studies of vonoprazan‐containing Helicobacter pylori eradication therapy suggest Thailand may be more similar to the US than Japan	1
Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infection	1
Helicobacter pylori infection reduces the efficacy of cancer immunotherapy: A systematic review and meta‐analysis	1
Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review	1
Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection	1
Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection	1
Association between genetic polymorphisms of NOD1, Interleukin‐1B, and cagA strain with low‐grade duodenal eosinophilia in Helicobacter pylori‐related dyspepsia	1
Antibiotic resistance patterns of Helicobacter pylori in North Israel – A six‐year study	1
Comparison of Helicobacter pylori eradication rates between 7 and 14 days of tailored therapy according to clarithromycin resistance test: A randomized, multicenter, non‐inferiority study	1
Incidence of gastrointestinal malignancies increases in persons received eradication therapy for Helicobacter pylori: A cohort study	1
Influences ofHelicobacter pyloriinfection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development	1
Correction to Antimicrobial Resistance of Helicobacter pylori Isolated From Latin American Children and Adolescents (2008–2023): A Systematic Review	1
Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis	1
Helicobacter pylori infection and inflammasomes	1
The role of microbiota in gastric cancer: A comprehensive review	1
Vonoprazan and amoxicillin dual therapy for 14 days as the first‐line treatment of Helicobacter pylori infection: A non‐inferiority, randomized clinical trial	1
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication	1
	1
Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice	1
Helicobacter pylori infection and risk of multiple sclerosis: An updated meta‐analysis	1
Immunoinformatics‐Based Designing of Novel and Potent Multi‐Epitope PSA D15 and Cag11 Immunogens for Helicobacter pylori Immunodiagnostic Assay Development	1
Issue Information	1
Information quality of videos related to Helicobacter pylori infection on TikTok: Cross‐sectional study	1
Adaptation of an in‐house PCR for the detection of Helicobacter pylori and the mutations associated with macrolide resistance into ready‐to‐use PCR microwell strips	1
The best is the enemy of the good: Time for a biopsy‐sparing approach for Helicobacter pylori diagnosis and treatment in children in the COVID‐19 era?	1
Atrophic gastritis in Helicobacter pylori‐infected children	1
Corrigendum	1
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis	1
Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐l	1
A reconstructed genome‐scale metabolic model of Helicobacter pylori for predicting putative drug targets in clarithromycin and rifampicin resistance conditions	1
Correction to “Long‐Term Effects of Fecal Microbiota Transplantation on Gut Microbiota After Helicobacter pylori Eradication With Bismuth Quadruple Therapy: A Randomized Controlled Trial”	1
Helicobacter pylori infection is associated with the co‐occurrence of bacteria in the oral cavity and the gastric mucosa	1
Antibiotic susceptibility pattern of Helicobacter pylori against eight antibiotics: A study from North India	1
The recurrence rate ofHelicobacter pyloriin recent 10 years: A systematic review and meta‐analysis	1
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	1
	1
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing	1
Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population‐based cohort study	1
Virulence assessment of enterohepaticHelicobacterspecies carried by dogs using the wax moth larvaeGalleria mellonellaas infection model	1
Quantitative PCR of string‐test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptib	1
Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia)	1